Inhibitory proteins of Bacillus subtilis interact within the membrane to block intramembrane protease activity
Journal of Bacteriology · 2025
DOI: 10.1128/jb.00186-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bacteriology, 2025. Verfasst von Saikat Mandal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan, USA. Hauptthemen laut MEDLINE: Bacillus subtilis, Bacterial Proteins, Peptide Hydrolases, Cell Membrane. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIGMS NIH HHS, Michigan State University AgBioResearch.
Abstract (Originalsprache)
Intramembrane proteases (IPs) are crucial for diverse signaling pathways, including some that regulate the virulence of pathogenic bacteria. A better understanding of mechanisms controlling IP activity is necessary to guide therapeutic development. Bacillus subtilis SpoIVFB is an IP with two natural inhibitory proteins, BofA and SpoIVFA. These proteins form a complex with SpoIVFB and prevent it from cleaving Pro-σ K during endosporulation. We investigated proximity between BofA and SpoIVFA in the SpoIVFB inhibition complex using in vivo disulfide crosslinking in Escherichia coli . We discovered that two parts of the BofA C-terminal region are proximal to the SpoIVFA transmembrane segment (TMS). Our results support predictions that the BofA C-terminal region adopts an unusual structure within the membrane and interacts with the SpoIVFA TMS to block SpoIVFB cleavage of Pro-σ K . Endospore-forming Bacilli , including several pathogenic species, encode BofA and SpoIVFA orthologs, which likely interact in a similar fashion to inhibit their SpoIVFB ortholog. It may be possible to control SpoIVFB activity and hence endosporulation with modulators that target the interaction between BofA and SpoIVFA. IMPORTANCE Regulated intramembrane proteolysis (RIP) pathways govern important processes in all three domains of life. A key component of RIP pathways is an intramembrane protease (IP), which cleaves one or more substrates within a membrane. Developing modulators of IPs has been challenging, particularly for metallo-IPs. Bacterial metallo-IPs function in RIP pathways that control the virulence of many pathogens. SpoIVFB is a metallo-IP necessary for endosporulation of Bacillus subtilis . Endosporulation enhances the survival of pathogenic Bacilli , which encode orthologs of SpoIVFB and its natural inhibitory proteins BofA and SpoIVFA. Here, we present the first experimental evidence for contacts between BofA and SpoIVFA within the membrane-embedded SpoIVFB inhibition complex, providing foundations for a deeper understanding of mechanisms controlling metallo-IP activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan, USA.
ORCID-Profile: Saikat Mandal, Benjamin J Orlando, Lee Kroos
Förderung
- NIH HHS
- NIGMS NIH HHS
- Michigan State University AgBioResearch
- National Institutes of Health
Zitieren
APA
Mandal, S., Soriano, A., Erpelding, C., Ruffner, J., Smith, E., Orlando, B. J., & Kroos, L. (2025). Inhibitory proteins of Bacillus subtilis interact within the membrane to block intramembrane protease activity. Journal of Bacteriology. https://doi.org/10.1128/jb.00186-25
Vancouver
Mandal S, Soriano A, Erpelding C, Ruffner J, Smith E, Orlando BJ, et al. Inhibitory proteins of Bacillus subtilis interact within the membrane to block intramembrane protease activity. Journal of Bacteriology. 2025. doi:10.1128/jb.00186-25
BibTeX
@article{Mandal2025,
author = {Mandal, Saikat and Soriano, Alanah and Erpelding, Caroline and Ruffner, Jackson and Smith, Eric and Orlando, Benjamin J and Kroos, Lee},
title = {Inhibitory proteins of Bacillus subtilis interact within the membrane to block intramembrane protease activity},
journal = {Journal of Bacteriology},
year = {2025},
doi = {10.1128/jb.00186-25}
}
EUVIMED